There is an Escalating Rate of Osteoporosis Despite 25 Years of Drug Treatment Options
1 in 2 women and 1 in 4 men over 50 will suffer an osteoporosis related fracture
“Fearing Drugs’ Rare Side Effects, Millions Take their Chances With Osteoporosis”
— New York Times
Introducing OsteoBoost
OsteoBoost is the first vibration belt specifically designed for the prevention of osteoporosis.
SIMPLE YET EFFECTIVE
The OsteoBoost Vibration Belt applies gentle mechanical stimulation to the hips and spine to reduce bone loss and encourage bone growth.
BASED ON NASA RESEARCH
Leveraging 15 years of published research (starting with NASA) proving that vibration at a precise amplitude and frequency stimulates bones, OsteoBoost delivers the optimal therapeutic dose directly to the most vulnerable anatomy, the hips and spine.
CLINICAL RESEARCH
Currently being studied in a National Institutes of Health (NIH) funded clinical trial, based on a successful pilot study that showed a significant reduction in bone loss after just one treatment.
EASY AND CONVENIENT
Comfortable and as easy as putting on a belt, one 30 minute treatment per day while doing chores or walking the dog makes OsteoBoost easy to fit into any lifestyle.
Comparing Bone Mineral Density
There are over 1 million hip and spine fractures each year with the onset of osteoporosis
Many fractures could be prevented by mechanically stimulating the bones.
Bone health improvement potential based on recent study
(abstract published by the Orthopedic Research Society in 2018)
5-10 years of OsteoBoost treatment can delay the onset of osteoporosis by 20-25 years.
The OsteoBoost Difference
REDUCTION IN BONE LOSS ACTIVITY
In a recently published study, OsteoBoost induced an acute reduction in bone loss activity as measured by the biomarker NTx (mean: 14%, p<0.001).
COMPARABLE TO MEDICATION AND EXERCISE
Study results are consistent with the effects of high-impact exercise and osteoporosis medication.
GREAT PREVENTATIVE MEASURE
OsteoBoost can be used during osteopenia whereas the medications are only approved for osteoporosis.
HIGH COMPLIANCE
Compliance is high at over 80%.
Treatment Compliance Rate
Current medication treatments are underutilized with 75% of patients discontinuing their medication within 12 months.
OsteoBoost is easy and convenient to use, with high compliance and satisfaction ratings.
Compliance
How It Works
The OsteoBoost Vibration Belt is as simple as 1-2-3, and includes an auto-shutoff feature that ends treatment after 30 minutes. Use daily or at least 4 days a week for full treatment effect.
Easy to attach velcro secures it around the waist.
STEP 1
Simply press power and it begins the gentle vibration treatment.
STEP 2
Once treatment beings, you can go about your business.
STEP 3
Chan et al., 2013. The potential benefits and inherent risks of vibration as a non-drug therapy for the prevention and treatment of osteoporosis. Curr Osteoporos Rep 11: p. 36-44.
NASA Research Leads to Vibration Belt Technology
Developed from NASA proven technology, OsteoBoost takes vibration therapy to another level by delivering precise mechanical stimulation to the areas of the body that need it most, the hips and spine.
Our Team
Laura Yecies
CEO
Serial entrepreneur, formerly CEO at SyncThink, Catch (acq. Apple), and SugarSync (acq. J2). led multiple successful brands at Check Point, Netscape, Yahoo.
Derek Hillstrom
VP Engineering
PhD from UC Berkeley in Orthopedics. Former Manager at FDA, Division of Orthopedic Devices. Over 10 years of medical device R&D experience.
Meghan Griffin
Clinical Operations
Experienced running clinical trials for several novel medical devices.
Nina Peled
Regulatory
Regulatory expert experienced in obtaining FDA clearances/approvals of all types, including 510k, PMA, de novo, and EUA
Gabriel Griego
Marketing
Seasoned sales & marketing leader. Track-record of successfully designing and executing go-to-market for consumer/medical products. Led marketing for PowerBar, Game Ready, and AlterG.
Board Members
Laura Yecies
CEO
Serial entrepreneur, formerly CEO at SyncThink, Catch (acq. Apple), and SugarSync (acq. J2). led multiple successful brands at Check Point, Netscape, Yahoo.
Dan Burnett
Founder
Experienced entrepreneur; Founder of 10 startups with >$225M in investments for these companies. Track-record of bringing companies from concept to successful commercial launch.
Shane Mangrum
Founder
Physical Medicine and Rehabilitation (PM&R) physician at Polaris Spine in Atlanta, GA; Specialist in non-operative spine and musculoskeletal care. Dr. Mangrum is also a co-inventor of the OsteoBoost technology
Karen Drexler
MBA, BSE
Founded and ran Amira Medical through the sale to Roche, Manager at LifeScan and executed the sale to J&J, CEO of Sandstone Diagnostics, guest lecturer at Stanford, active board member at a variety of major medical device/diagnostic companies. Engineering background with deep business and entrepreneurial experience.
Dr. Nancy Lynch
MD, MBA
President of Advisorthopædics, Board-certified orthopedic surgeon and fellow of the American Academy of Orthopædic Surgeons. B.A. from the University of Notre Dame, M.D. from the Washington University School of Medicine, completed residency at the Mayo Clinic and an MBA from Duke. Experience as a venture capitalist, and as an executive within startup companies.
Dr. Sam Goldberger
MD, MBA
Co-Founder and Managing Partner of Ambit Health Ventures. Ophthalmologist and ophthalmic surgeon. Board certified by the American Academy of Ophthalmology and member of the American Society of Ophthalmic Plastic & Reconstructive Surgery. MD from Albert Einstein College of Medicine, and MBA from MIT Sloan. Led a successful ophthalmology practice roll up and founded a healthcare and life-science investing firm.
John Osborne
BS
Over a decade working various roles in the finance industry including in commercial banking, private banking and angel investing. Co-founded and Director of The Harbor Entrepreneur Center, Charleston. Executive Administrator of Charleston Angel Partners. B.S. in Finance from Charleston Southern University
Advisors & Investigators
Harold Rosen
MD
Professor of Endocrinology at Harvard Medical School, Director Osteoporosis Prevention and Treatment Center at Beth Israel Deaconess Medical Center, leading expert in bone densitometry, biochemical markers of bone turnover and metabolic bone disease.
David B. Karpf
MD
Professor of Endocrinology at Stanford University School of Medicine, Director Stanford Osteoporosis and Metabolic Bone Disease Clinic, leading researcher on Osteoporosis medications (Fosomax trial) and board member of American Bone Health
Dolores Shoback
MD
Professor of Medicine, UCSF, Staff Physician San Francisco, VA, and board member of American Bone Health. Dr. Shoback is a recognized authority in metabolic bone disease, parathyroid disorders and osteoporosis. She also co-directs UCSF’s physician training program in diabetes, endocrinology and metabolism.
Anne Schafer
MD
Chief of Endocrinology and Metabolism San Francisco, VA, Associate Professor of Medicine and Epidemiology & Biostatistics at UCSF. Dr. Schafer is an expert on optimizing osteoporosis treatment and the relationships between bone, fat, and glucose metabolism.
Laura Bilek
PhD, PT
Associate Dean for Research in the College of Allied Health Professions at the University of Nebraska Medical Center (UNMC). Expert in clinical research for the treatment of low bone mass.
Tony Keaveny
PhD
Professor of Mechanical Engineering and Bioengineering, UC Berkeley, director of the Berkeley Orthopaedic Biomechanics Lab; Expert in bone mechanics and inventor of VirtuOst.
Investors
54 million Americans have osteopenia or osteoporosis
Now they have a good option to help prevent fractures
that is easy to use and fits into their daily lifestyle
